Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bigby

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Archives of Dermatology|September 19, 2012
Outcome measures in dermatology: comment on "measurement properties of outcome measures for vitiligo"Michael Bigby
Archives of Dermatology|June 20, 2012
The use of anti-interleukin-12/23 agents and major adverse cardiovascular eventsMichael Bigby
Journal of the American Academy of Dermatology|October 1, 2019
Rifampin and clindamycin are safe long-term: Response to "North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management"Joerg Albrecht, Michael Bigby
Archives of Dermatology|June 18, 2003
Appraising systematic reviews and meta-analysesMichael Bigby, Hywel Williams
Archives of Dermatology|April 13, 2011
Testing a test: critical appraisal of tests for diagnosing scabiesJoerg Albrecht, Michael Bigby
Archives of Dermatology|December 17, 2008
Treating scabies: results from an updated Cochrane reviewStephanie Hu, Michael Bigby
Journal of the American Academy of Dermatology|January 11, 2003
The meaning of "safe and effective"Joerg Albrecht, Michael Bigby
BMJ (Clinical Research Ed.)|November 12, 2015
Sentinel lymph node biopsy in melanomaMichael Bigby, Catalin Popescu
Archives of Dermatology|July 18, 2012
Randomized controlled trial of cryotherapy with liquid nitrogen vs topical salicylic acid vs wait-and-see for cutaneous wartsJustin Ko, Michael Bigby
Journal of the American Academy of Dermatology|November 30, 2020
Platelet-rich plasma lacks evidence of clinically significant improvement in androgenetic alopeciaMichael Bigby, Ramon Grimalt
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Archives of Dermatology|September 19, 2012
Outcome measures in dermatology: comment on "measurement properties of outcome measures for vitiligo"Michael Bigby
Archives of Dermatology|June 20, 2012
The use of anti-interleukin-12/23 agents and major adverse cardiovascular eventsMichael Bigby
Journal of the American Academy of Dermatology|October 1, 2019
Rifampin and clindamycin are safe long-term: Response to "North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management"Joerg Albrecht, Michael Bigby
Archives of Dermatology|June 18, 2003
Appraising systematic reviews and meta-analysesMichael Bigby, Hywel Williams
Archives of Dermatology|April 13, 2011
Testing a test: critical appraisal of tests for diagnosing scabiesJoerg Albrecht, Michael Bigby
Archives of Dermatology|December 17, 2008
Treating scabies: results from an updated Cochrane reviewStephanie Hu, Michael Bigby
Journal of the American Academy of Dermatology|January 11, 2003
The meaning of "safe and effective"Joerg Albrecht, Michael Bigby
BMJ (Clinical Research Ed.)|November 12, 2015
Sentinel lymph node biopsy in melanomaMichael Bigby, Catalin Popescu
Archives of Dermatology|July 18, 2012
Randomized controlled trial of cryotherapy with liquid nitrogen vs topical salicylic acid vs wait-and-see for cutaneous wartsJustin Ko, Michael Bigby
Journal of the American Academy of Dermatology|November 30, 2020
Platelet-rich plasma lacks evidence of clinically significant improvement in androgenetic alopeciaMichael Bigby, Ramon Grimalt
Pageof 5